Emeritus (Seattle) said that it has filed an application to list its common stock on the New York Stock Exchange (NYSE) and expects to begin trading on the NYSE on Sept. 17, subject to approval by the NYSE, under the stock symbol "ESC." Until that time, the company's shares will continue to trade on the American Stock Exchange.

To mark this milestone, the company will ring the opening bell at the NYSE on Wednesday.

Daniel Baty, chairman/co-CEO of Emeritus, said, "Our move to the NYSE is an important next step for Emeritus, and we look forward to joining the many leading companies that are part of this exchange. We believe our association with the NYSE will help to further raise our visibility within the investment community as we continue to focus on providing high-quality resident care and continued growth. We would also like to thank the American Stock Exchange for its service and support over the years."

Emeritus is a provider of assisted living and Alzheimer's and related dementia care services to seniors.

Study: Black women less likely to get radiation

According to a new study, African American women with breast cancer who have a lumpectomy are less likely to receive radiation treatment compared to white women-the standard for early stage breast cancer. Radiation therapy reduces both the chance of recurrence and improves the chance of survival.

The study by the University of Texas M.D. Anderson Cancer Center (Houston) researchers is the largest of its kind and will be among the many breast cancer issues addressed during Sisters Network Inc. 10th National African American Breast Cancer survivorship conference on Sept. 19-21 at the Intercontinental Hotel in Houston.

"The M.D. Anderson Cancer Center study not only confirms the serious problem of African American breast cancer patients not receiving the same quality of care as white women, it also reinforces the important and much needed voice Sisters Network continues to contribute as the nation's leading advocate for African American breast cancer survivorship," said Karen Jackson, founder/CEO, Sisters Network.

Ancillary Care changes name to NovoLogix

Ancillary Care Management (Minneapolis), a healthcare technology company, said that it has changed its corporate name to NovoLogix.

"Building on the company's ... 13-year track record servicing healthcare clients across the country, our new name captures the essence of the technology-driven processes and fresh thinking that have been the hallmarks of our success," said CEO David McLean.

He added, "Healthcare has evolved dramatically over the past decade, particularly in the home health/ancillary care field: changing economic demands and government mandates, the flood of biopharmaceuticals in the market, shifting sites of care, and the administration support required for many of the new drug therapies."

NovoLogix makes technology applications, systems and processes to impact both the economics and quality of how services and drugs are priced, paid for, and delivered to patients across the U.S.

Radiation coalition examines dose estimates

Medical imaging equipment manufacturers have agreed to work with the Alliance for Radiation Safety in Pediatric Imaging to create standardized radiation dose estimates and vendor-sponsored technologist education opportunities.

"This is an example of how all stakeholders in the medical imaging community can and must work together for the good of our pediatric patients and our profession. This summit and our subsequent agreement to work together, represents a major step forward in ensuring that medical protocols keep pace with rapidly advancing technology and are properly displayed on our CT equipment," said Marilyn Goske, MD, chair of the Alliance for Radiation Safety in Pediatric Imaging.

The alliance met Aug. 20 with a coalition of 29 organizations focused on reducing radiation dose estimates that children receive via medical imaging.

"This agreement is a fundamental change in responsibility and accountability for the dose estimates that our children – and actually adults, too – receive during CT examinations," said Donald Frush, MD, chair of the Pediatric Imaging Commission of the American College of Radiology (ACR; Reston, Virginia).

Currently, dose capture and reporting systems can vary depending on the manufacturer, making comparisons difficult, according to the ACR. Also, dose estimates for CT scans can underestimate the radiation dose utilized in pediatric imaging because the estimates are often developed using adult phantoms.